Product Development Policy | Research & Development | SENJU Pharmaceutica
ntribute to maintenance and improvement of “a joy to behold” or QOV (Quality of Vision) of patients worldwide. We commercialized senile cataract drugs in 1958, and subsequently, antimicrobial ophthalm...
http://www.senju.co.jp/english/rd/policy/
医療用医薬品 
医療機器 
動物用医薬品 
OTC医薬品 
サプリメント 